SBRT radiation plus immunotherapy for limited spread melanoma
Part of Cancer, Immune system & allergy clinical trials.
This trial tests if combining targeted radiation (SBRT) with standard immunotherapy works better for melanoma that has spread to a few spots in the body (but not the brain). It is for people who have not yet had treatment for their current spread.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- Your melanoma has spread to 1 to 5 spots outside your brain, but not in the brain itself.
- You have not had radiation for melanoma that has spread (radiation after surgery for early-stage is okay).
- You have not received drug treatment for your current spread (except possibly after surgery for early-stage melanoma).
- You are healthy enough to have radiation and immunotherapy, and your doctor thinks you can tolerate them.
- All your melanoma spots can be treated with a special high-dose radiation called SBRT.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether giving the immunotherapy drug nivolumab together with targeted brain radiation (not whole-brain radiation) helps people with melanoma that has spread to the brain. It aims to improve brain control while keeping side effects manageable.
This study tests a very focused form of radiation for melanoma that has spread and has stopped responding to PD-1 (and sometimes CTLA-4) immunotherapy. It may help by shrinking progressing spots while keeping the immune treatment going.
This trial combines targeted radiation (SBRT) with an immunotherapy drug (PD-1 inhibitor) to treat colorectal cancer that has spread to the liver and can't be removed by surgery. It aims to help shrink or control tumors in patients whose cancer has a normal DNA repair system (pMMR/MSS).
This trial looks at adding a focused radiation treatment called SBRT to standard care for cancers that have spread to a limited number of spots. It aims to control those spread-out tumors while still using the usual cancer treatment plan.
This study tests whether giving precise radiation to a limited number of growing spots can help control melanoma that has spread but is otherwise stable on immunotherapy or targeted therapy. You may join if you have up to 10 growing spots outside the brain that can be safely treated with focused radiation.
This trial combines a special high-dose radiation (SBRT) with immunotherapy to treat esophageal cancer that has spread to a few spots in the body (up to 5 spots in up to 3 organs). The goal is to see if this approach can better control the cancer.
Hear when a new Melanoma Metastatic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.